Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Microbot Medical, Inc. Common Stock (MBOT)

Surgical & Medical Instruments & Apparatus

https://microbotmedical.com

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

25 RECREATION PARK DR SUITE 108
HINGHAM, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/25/1992

Market Cap

16,763,880

Shares Outstanding

13,390,000

Weighted SO

13,392,999

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

SDC --.--%

ISRG --.--%

INND --.--%

POAI --.--%

STAA --.--%

BDX --.--%

WST --.--%

RMD --.--%

GCTK --.--%

Beta

1.6770

Last Div

0.0000

Range

0.85-2.35

Chg

0.0500

Avg Vol

2741604

Mkt Cap

16763880

Exch

NASDAQ

Country

US

Phone

781 875 3605

DCF Diff

0.8060

DCF

0.2241

Div Yield

0.0000

P/S

118.0555

EV Multiple

-1.5302

P/FV

2.5746

Div Yield %

0.0000

P/E

-1.4938

PEG

0.0139

Payout

0.0000

Current Ratio

5.3229

Quick Ratio

5.3229

Cash Ratio

1.8740

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

669.7938

CCC

-669.7938

Gross Margin

0.3169

Op Margin

-66.9507

Pretax Margin

-73.4930

Net Margin

-73.4930

Eff Tax Rate

-0.0106

ROA

-1.4038

ROE

-1.7335

ROCE

-1.5603

NI/EBT

1.0000

EBT/EBIT

1.0977

EBIT/Rev

-66.9507

Debt Ratio

0.0199

D/E

0.0244

LT Debt/Cap

0.0062

Total Debt/Cap

0.0239

Int Coverage

-144.0455

CF/Debt

-53.0608

Equity Multi

1.2277

Rec Turnover

0.0000

Pay Turnover

0.5449

Inv Turnover

0.0000

FA Turnover

0.4797

Asset Turnover

0.0191

OCF/Share

-0.5289

FCF/Share

-0.5317

Cash/Share

0.4385

OCF/Sales

-55.3028

FCF/OCF

1.0052

CF Coverage

-53.0608

ST Coverage

-71.3909

CapEx Coverage

-191.5366

Div&CapEx Cov

-191.5366

P/BV

2.5746

P/B

2.5746

P/S

118.0555

P/E

-1.4938

P/FCF

-2.1236

P/OCF

-1.9851

P/CF

-1.9851

PEG

0.0139

P/S

118.0555

EV Multiple

-1.5302

P/FV

2.5746

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 18, 07:20 Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study Benzinga Dec 29, 12:19 Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet GlobeNewswire Inc. Dec 28, 07:30 Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met GlobeNewswire Inc. Nov 21, 09:12 Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Revenue Product Segmentation